Delivery Order SPE2DB22D3501-SPE2DB25FUE69

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.16 firm fixed-price delivery order contract is for the supply of 4566949376 - Dextroamphetamine-Amphetamine 25 mg Capsules. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This award is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,480.78 firm-fixed-price delivery order is for the supply of 4,566,111,129 units of the drug Dextroamphetamine-Amphetamine 25 mg capsules. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.56 Firm Fixed Price Delivery Order is for the supply of Dextroamphetamine-Amphetamine 20 mg capsules and has a completion date of February 27, 2024. The award is not designated as a set-aside contract. It appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,830.47 firm-fixed-price delivery order is for the supply of 4,565,712,396 units of dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of September 9, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $1,260.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,334,653 units of dextroamphetamine-amphetamine 15 mg capsules, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,776,079 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The $1,126.92 firm fixed-price contract has a completion date of December 23, 2024. It is not designated as a set-aside contract. This award appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for $2,097.52. The order is for Dextroamphetamine-Amphetamine 25 mg capsules, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.96 firm-fixed-price delivery order is for the supply of 4,566,251,250 capsules of 25mg dextroamphetamine-amphetamine, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,251,334 units of Dextroamphetamine-Amphetamine 15 mg capsules. The $3,337.47 Firm Fixed Price delivery order has a completion date of September 18, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds two Indefinite Delivery Contracts (IDCs) with the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUE69
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.88, is a Firm Fixed Price Delivery Order for the procurement of Dextroamphetamine-Amphetamine 25 mg capsules. The contract has an ultimate completion date of January 21, 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside designation, suggesting open competition.

Generated 4/18/25, 2:18 PM